Our medical expertise includes: Medical Director of clinical laboratory services, microbiology and infectious disease specialist, oncologists, pathologists, and molecular biologist each with more than 25 years’ experience.
Our corporate expertise includes:
- Patenting proprietary intellectual properties
- Development of new test panels within 4-6 weeks
- Patented and proprietary Quality Control protocols
- Commissioning of clinical laboratories (CLIA/CAP)
- Test validation with medical centers of excellence
- Testing and reporting patient samples
- Recipient of Medicare and third-party payments for routine testing.
- Presentations at US and international medical conferences
- Peer reviewed publications
- FDA submission
- First to develop a molecular test to detect SARS-CoA (2003)
- First to develop DNA sequencing test panel for SARS-CoA, MERS-CoA and COVID-19